Xi'an International Medical Investment Company Limited is currently in a long term uptrend where the price is trading 28.5% above its 200 day moving average.

From a valuation standpoint, the stock is 275.2% more expensive than other stocks from the Consumer Cyclical sector with a price to sales ratio of 19.3.

Xi'an International Medical Investment Company Limited's total revenue rose by 88.6% to $432M since the same quarter in the previous year.

Its net income has dropped by 510.0% to $-154M since the same quarter in the previous year.

Finally, its free cash flow grew by 55.3% to $-372M since the same quarter in the previous year.

Based on the above factors, Xi'an International Medical Investment Company Limited gets an overall score of 3/5.